Literature DB >> 11950817

Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.

J P H Drenth1, R te Morsche, J B M J Jansen.   

Abstract

BACKGROUND: Although chronic pancreatitis is associated with risk factors such as alcoholism, hyperparathyroidism, and hypertriglyceridaemia, little is known of the actual aetiology of the disease. It is thought that inappropriate activation of trypsinogen causes pancreatitis, and indeed in cases of hereditary pancreatitis mutations of cationic trypsinogen (PRSS1) have been described. As serine protease inhibitor Kazal type 1 (SPINK1) is a potent natural inhibitor of pancreatic trypsin activity, we hypothesised that SPINK1 mutations would be more common than expected among an unselected cohort of adult chronic pancreatitis patients. AIMS: To detect the prevalence of SPINK1 mutations in a cohort of chronic pancreatitis patients.
METHODS: DNA was isolated from a cohort of 115 adult patients with chronic pancreatitis of alcoholic (n=72), hereditary (n=10), idiopathic (n=24), and miscellaneous (n=9) origin. We performed mutational analysis for two PRSS1 mutations (R122H, N29I) and four specific SPINK1 gene mutations (M1T, L14P, N34S, P55S) and compared the results with a control group of 120 healthy Dutch subjects.
RESULTS: In six of the 10 patients that fulfilled the criteria for hereditary pancreatitis, but in none of the control subjects, mutations in the PRSS1 gene were found. In 14 patients we detected a SPINK1 mutation. Eleven patients were heterozygous for the N34S mutation and sequencing confirmed the homozygous state of N34S in a brother and sister. Two patients carried the P55S mutation, one as a compound heterozygote with N34S. The M1T and L14P SPINK1 mutations were not found in our cohort. The N34S mutation was detected in only two of 120 controls, while the P55S, M1T, and L14P mutations were absent in the same group. Patients with the N34S allele had a later onset of disease than those with PRSS1 gene mutations but earlier onset compared with the mutation negative group.
CONCLUSION: Identification of SPINK1 mutations in 12.2% of patients with adult alcoholic and idiopathic chronic pancreatitis suggests an important role for SPINK1 as a predisposing factor in adult chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950817      PMCID: PMC1773221          DOI: 10.1136/gut.50.5.687

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Strong evidence that the N21I substitution in the cationic trypsinogen gene causes disease in hereditary pancreatitis.

Authors:  J M Chen; B Mercier; C Ferec
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  The natural history of pain in alcoholic chronic pancreatitis.

Authors:  R W Ammann; B Muellhaupt
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

3.  A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis.

Authors:  R W Ammann
Journal:  Pancreas       Date:  1997-04       Impact factor: 3.327

4.  Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene.

Authors:  D C Whitcomb; M C Gorry; R A Preston; W Furey; M J Sossenheimer; C D Ulrich; S P Martin; L K Gates; S T Amann; P P Toskes; R Liddle; K McGrath; G Uomo; J C Post; G D Ehrlich
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

5.  Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis.

Authors:  M C Gorry; D Gabbaizedeh; W Furey; L K Gates; R A Preston; C E Aston; Y Zhang; C Ulrich; G D Ehrlich; D C Whitcomb
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

6.  A gene for hereditary pancreatitis maps to chromosome 7q35.

Authors:  D C Whitcomb; R A Preston; C E Aston; M J Sossenheimer; P S Barua; Y Zhang; A Wong-Chong; G J White; P G Wood; L K Gates; C Ulrich; S P Martin; J C Post; G D Ehrlich
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

7.  Screening for mutations of the cationic trypsinogen gene: are they of relevance in chronic alcoholic pancreatitis?

Authors:  N Teich; J Mössner; V Keim
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

8.  Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.

Authors:  N Sharer; M Schwarz; G Malone; A Howarth; J Painter; M Super; J Braganza
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

9.  Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

Authors:  J A Cohn; K J Friedman; P G Noone; M R Knowles; L M Silverman; P S Jowell
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

10.  The hereditary pancreatitis gene maps to long arm of chromosome 7.

Authors:  L Le Bodic; J D Bignon; O Raguénès; B Mercier; T Georgelin; M Schnee; F Soulard; K Gagne; F Bonneville; J Y Muller; L Bachner; C Férec
Journal:  Hum Mol Genet       Date:  1996-04       Impact factor: 6.150

View more
  39 in total

1.  The SPINK in chronic pancreatitis: similar finds, different minds.

Authors:  H Witt
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients.

Authors:  Ada Piepoli; Annamaria Gentile; Maria Rosa Valvano; Daniela Barana; Cristina Oliani; Rosa Cotugno; Michele Quitadamo; Angelo Andriulli; Francesco Perri
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

3.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

4.  Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis.

Authors:  Orsolya Király; Arnaud Boulling; Heiko Witt; Cédric Le Maréchal; Jian-Min Chen; Jonas Rosendahl; Cinzia Battaggia; Thomas Wartmann; Miklós Sahin-Tóth; Claude Férec
Journal:  Hum Mutat       Date:  2007-05       Impact factor: 4.878

5.  Evaluating Adults With Idiopathic Pancreatitis for Genetic Predisposition: Higher Prevalence of Abnormal Results With Use of Complete Gene Sequencing.

Authors:  Darren D Ballard; Joyce R Flueckiger; Evan L Fogel; Lee McHenry; Glen A Lehman; James L Watkins; Stuart Sherman; Gregory A Coté
Journal:  Pancreas       Date:  2015-01       Impact factor: 3.327

6.  Elevated intracellular trypsin exacerbates acute pancreatitis and chronic pancreatitis in mice.

Authors:  Xianbao Zhan; Jianhua Wan; Guowei Zhang; Lele Song; Fu Gui; Yuebo Zhang; Yinghua Li; Jia Guo; Rajinder K Dawra; Ashok K Saluja; Ashley N Haddock; Lizhi Zhang; Yan Bi; Baoan Ji
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-04-03       Impact factor: 4.052

7.  Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis.

Authors:  Kwang Hyuck Lee; Ji Kon Ryu; Won Jae Yoon; Jun Kyu Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

8.  Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.

Authors:  G R Chandak; M M Idris; D N Reddy; K R Mani; S Bhaskar; G V Rao; L Singh
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Protection against chronic pancreatitis and pancreatic fibrosis in mice overexpressing pancreatic secretory trypsin inhibitor.

Authors:  Jaimie D Nathan; Joelle Romac; Ruth Y Peng; Michael Peyton; Don C Rockey; Rodger A Liddle
Journal:  Pancreas       Date:  2010-01       Impact factor: 3.327

10.  Polymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis.

Authors:  Aura A J van Esch; Mark P Lamberts; René H M te Morsche; Martijn G H van Oijen; Jan B M J Jansen; Joost P H Drenth
Journal:  BMC Gastroenterol       Date:  2009-12-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.